文献速递临床试验与 GCP流行病学与生物统计

极早产儿脑氧监测与常规护理比较:SafeBoosC-III随机临床试验参与者2年随访的详细统计分析计划

Cerebral oximetry monitoring versus usual care for extremely preterm infants: a detailed statistical analysis plan for the 2-year follow-up of the participants of the SafeBoosC-III randomised clinical trial.
PubMed 文献 · Trials · 2026-01-05

SafeBoosC-III试验显示,极早产儿出生后72小时内脑氧监测指导治疗与常规护理相比,在36周矫正胎龄时对死亡率或严重脑损伤无影响。本统计分析计划在数据收集完成前制定,旨在评估2年矫正年龄时的长期获益与危害。

要点

  • 共同主要结局为死亡或中重度神经发育障碍的复合结局,以及Bayley-III/IV认知评分均值。
  • 采用三级数据模型整合常规临床随访、家长问卷和非正式评估以减少缺失数据。
  • 所有有数据的随机参与者均纳入分析,使用混合效应线性和逻辑回归分析连续和二分共同主要结局。

核心结论

  • 本统计分析计划旨在确保透明度并减少结局报告偏倚,通过纳入二分和连续共同主要结局全面评估干预的长期获益与危害。

研究设计与样本

  • SafeBoosC-III随访研究为前瞻性计划,纳入极早产儿(出生胎龄低于28周)随机参与者,在2年矫正年龄时评估结局。

主要发现

  • 共同主要结局为死亡或中重度神经发育障碍的复合结局,以及Bayley-III/IV认知评分均值。
  • 采用三级数据模型(常规临床随访、家长问卷、非正式评估)以减少缺失数据。
  • 所有有数据的随机参与者均纳入分析,使用混合效应线性和逻辑回归分析连续和二分共同主要结局。
  • 进行敏感性分析以处理缺失数据并评估结果的稳健性。

关键数值与推荐

  • 共同主要结局:死亡或中重度神经发育障碍的复合结局;Bayley-III/IV认知评分均值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The SafeBoosC-III trial investigated treatment guided by cerebral oximetry monitoring for the first 72 h after birth in extremely preterm infants (born below 28 weeks gestational age) and showed no effects on mortality or severe brain injury at 36 weeks' postmenstrual age versus usual care. As severe brain injury in the neonatal period is not a strong predictor of long-term neurodevelopmental outcomes, the prospectively planned SafeBoosC-III follow-up study aims to assess the long-term benefits and harms of the experimental intervention versus usual care at 2 years of corrected age. The statistical analysis plan presented here was defined before data collection was complete and outlines our approach for analysing outcomes in the SafeBoosC-III follow-up study. METHODS: The co-primary outcomes were (1) a composite of death or moderate-to-severe neurodevelopmental disability and (2) the mean Bayley-III/IV cognitive score. We employed a 3-tier data model, incorporating routine clinical follow-up, parental questionnaires, and informal assessments to minimise missing data. All randomised participants with available data were included in all analyses. Mixed-effect linear and logistic regression was used to analyse the dichotomous and continuous co-primary outcomes, respectively. Sensitivity analyses were conducted to address missing data and assess the robustness of our findings. DISCUSSION: This statistical analysis plan aimed to ensure transparency and reduce the risk of outcome reporting bias. By including dichotomous and continuous co-primary outcomes, we aimed to provide a comprehensive evaluation of the intervention's effect on long-term benefits and harms. TRIAL REGISTRATION: ClinicalTrials.gov NCT05134116 . Registered on November 24, 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Rasmussen MIS, Hansen ML, Pellicer A, et al. Cerebral oximetry monitoring versus usual care for extremely preterm infants: a detailed statistical analysis plan for the 2-year follow-up of the participants of the SafeBoosC-III randomised clinical trial. Trials. 2026. PMID: 41491571. doi:10.1186/s13063-025-09392-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。